These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26695513)

  • 1. Newly Emerging Theranostic Agents for Simultaneous Cancertargeted Imaging and Therapy.
    Luo S; Yang X; Shi C
    Curr Med Chem; 2016; 23(5):483-97. PubMed ID: 26695513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
    Sharma R; Mody N; Agrawal U; Vyas SP
    Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal nanoparticles: a theranostic nanotool against cancer.
    Sharma H; Mishra PK; Talegaonkar S; Vaidya B
    Drug Discov Today; 2015 Sep; 20(9):1143-51. PubMed ID: 26007605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional theranostic nanoplatform for cancer combined therapy based on gold nanorods.
    Chen WH; Yang CX; Qiu WX; Luo GF; Jia HZ; Lei Q; Wang XY; Liu G; Zhuo RX; Zhang XZ
    Adv Healthc Mater; 2015 Oct; 4(15):2247-59. PubMed ID: 26333115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small conjugate-based theranostic agents: an encouraging approach for cancer therapy.
    Kumar R; Shin WS; Sunwoo K; Kim WY; Koo S; Bhuniya S; Kim JS
    Chem Soc Rev; 2015 Oct; 44(19):6670-83. PubMed ID: 26118960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application and Importance of Theranostics in the Diagnosis and Treatment of Cancer.
    Jeyamogan S; Khan NA; Siddiqui R
    Arch Med Res; 2021 Feb; 52(2):131-142. PubMed ID: 33423803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
    Ma Y; Huang J; Song S; Chen H; Zhang Z
    Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and opportunities in the development of metal-based anticancer theranostic agents.
    Vaidya SP; Gadre S; Kamisetti RT; Patra M
    Biosci Rep; 2022 May; 42(5):. PubMed ID: 35420649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
    Tripathi P; Shukla P; Bieberich E
    Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multifunctional Theranostic Nanoagent for Dual-Mode Image-Guided HIFU/Chemo- Synergistic Cancer Therapy.
    Zhang N; Cai X; Gao W; Wang R; Xu C; Yao Y; Hao L; Sheng D; Chen H; Wang Z; Zheng Y
    Theranostics; 2016; 6(3):404-17. PubMed ID: 26909114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, preparation, and in vitro characterization of a trimodally-targeted nanomagnetic onco-theranostic system for cancer diagnosis and therapy.
    Zarrin A; Sadighian S; Rostamizadeh K; Firuzi O; Hamidi M; Mohammadi-Samani S; Miri R
    Int J Pharm; 2016 Mar; 500(1-2):62-76. PubMed ID: 26721723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pH-Responsive Yolk-Like Nanoplatform for Tumor Targeted Dual-Mode Magnetic Resonance Imaging and Chemotherapy.
    Sun X; Du R; Zhang L; Zhang G; Zheng X; Qian J; Tian X; Zhou J; He J; Wang Y; Wu Y; Zhong K; Cai D; Zou D; Wu Z
    ACS Nano; 2017 Jul; 11(7):7049-7059. PubMed ID: 28665575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multifunctional heptamethine near-infrared dye for cancer theranosis.
    Luo S; Tan X; Qi Q; Guo Q; Ran X; Zhang L; Zhang E; Liang Y; Weng L; Zheng H; Cheng T; Su Y; Shi C
    Biomaterials; 2013 Mar; 34(9):2244-51. PubMed ID: 23261220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic barcoded nanoparticles for personalized cancer medicine.
    Yaari Z; da Silva D; Zinger A; Goldman E; Kajal A; Tshuva R; Barak E; Dahan N; Hershkovitz D; Goldfeder M; Roitman JS; Schroeder A
    Nat Commun; 2016 Nov; 7():13325. PubMed ID: 27830705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics.
    Min HS; You DG; Son S; Jeon S; Park JH; Lee S; Kwon IC; Kim K
    Theranostics; 2015; 5(12):1402-18. PubMed ID: 26681985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine.
    Chen F; Hong H; Goel S; Graves SA; Orbay H; Ehlerding EB; Shi S; Theuer CP; Nickles RJ; Cai W
    ACS Nano; 2015; 9(4):3926-34. PubMed ID: 25843647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal Nanotechnology for Cancer Theranostics.
    Yue X; Dai Z
    Curr Med Chem; 2018; 25(12):1397-1408. PubMed ID: 28266269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis.
    Kundu P; Singh D; Singh A; Sahoo SK
    Anticancer Agents Med Chem; 2020; 20(11):1288-1299. PubMed ID: 31429694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and Functionalization of the NIR-Responsive Photothermal Semiconductor Nanomaterials for Cancer Theranostics.
    Huang X; Zhang W; Guan G; Song G; Zou R; Hu J
    Acc Chem Res; 2017 Oct; 50(10):2529-2538. PubMed ID: 28972736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.